Flash FinanceUS
Market closed S&P 5007,549.94+2.35% Nasdaq25,253.14+2.74% Dow 3052,389.75+2.15% Russell 20002,840.81+3.15% Nasdaq-10027,907.62+3.40% MidCap 4003,715.23+3.13% SmallCap 6001,722.37+2.89% VIX19.92-22.31% 10Y Yield4.86+0.10% Close of Nov 09, 2026
AI brief of an SEC Form 8-K · Senti Biosciences Holdings, Inc. (SNTI)

Senti Biosciences adjourns annual meeting to Oct. 15 to seek more votes on merger

Neutral Impact 3 of 5 m&a Written later

Senti Biosciences adjourned its virtual 2026 Annual Meeting of Stockholders on October 8, 2026 without conducting any business, though a quorum was present. The company said it needs more time to solicit stockholder votes in favor of the Merger Agreement Proposal, and the meeting will reconvene on October 15, 2026. For shareholders, the vote on the proposed merger remains open, and no changes were made to the proposals.

Key points

  • Annual Meeting convened October 8, 2026 and adjourned without conducting business; a quorum was present
  • Meeting reconvenes Thursday, October 15, 2026 at 8:00 a.m. Pacific time, virtually
  • Company is seeking more votes in favor of the Merger Agreement Proposal; polls remain open and no proposals changed
  • Record date remains September 23, 2026; stockholders who already voted need not act

The filing

CompanySenti Biosciences Holdings, Inc. (SNTI)
Form8-K, current report
Filed with the SECOct 13, 2026, 4:01 PM ET
Accession number0001628280-26-065685

Items reported: 8.01 Other Events

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 11:44 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 13, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.